Notify me when Dipan Patel files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | Class A Common Stock, par value $0.01 | 7.6% | $239M | 23.8M | 0% | Patel Dipan | Oct 3, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|